Snackable Studies

Study overviews, bite-sized
Lupus nephritis
Gazyvaro Lupus Nephritis
At a glance: Obinutuzumab achieved higher rates of histologic remission compared to placebo (adjusted difference, 30.75%), even among clinical CRR non-responders.
Browse the study
Back to service portal

All references can be found in the respective news article.

Gazyvaro® prescribing information can be found at www.swissmedicinfo-pro.ch.
Roche Pharma (Switzerland) Ltd assumes no responsibility for the accuracy, legality, or content of the external site or any subsequent links. Please note that by leaving the Swiss HCP portal, you accept that information on external websites may not align with the product's approved use in Switzerland. The Swiss prescribing information remains the primary source of information for Swiss HCPs. Should you have any questions regarding the content of the external site, please contact them directly.
Restricted

Bookmarking is available only for logged-in users.

Sign up Log in